Franklin Genomic Advancements ETF
Franklin Resources, Inc. HELX ETF
| HELX Price | $31.6075 |
Market Cap | $21.02M |
| Annual Dividend Yield | 0.46% |
Annual Dividend | $0.14 |
| Yearly Management Fee | 0.50% |
Asset Class | Equity |
| Focus | Theme |
Category | Sector, Theme |
| Niche | Genomic advancements |
Last 24h Volume | $40 |
| Portfolio Management Company | Franklin Resources, Inc. |
Discount/Premium to NAV | -0.06% |
| Inception Date | Feb 25, 2020 |
Market Cap Rank | 3782 |
| Monthly AUM Growth | -6.21% |
Holdings Region | Global |
| Management Style | Active |
Leverage | Non-Leveraged |
Franklin Genomic Advancements ETF is an ETF issued by Franklin Resources, Inc. on Feb 25 2020.
The main focus of this ETF, which is in the "Equity" asset class, is determined as "Theme".
As of today, the price of HELX ETF according to its net asset value is discounted at -0.06%.
While the total value of the fund shows $-1,391,001 decrease compared to the previous month, its price is traded daily at a increase of 1.17%.
The annual dividend yield of HELX ETF is 0.46%, whereas its main asset area is Global.
HELX ETF, whose 24-hour total volume is $40, has experienced a $0 cash outflow in the last month.
In addition, Franklin Genomic Advancements ETF's one-year net asset value total return is 12.24%.
HELX ETF Returns
| Daily |
Weekly |
Monthly |
3 Mo |
6 Mo |
YTD |
Yearly |
| 1.17% |
-1.22% |
-7.85% |
-13.62% |
-0.13% |
-12.90% |
15.44% |
HELX ETF NAV Total Return
| Monthly |
3 Mo |
YTD |
Yearly |
3 Years |
5 Years |
| -10.11% |
-15.99% |
-13.86% |
12.24% |
4.23% |
8.01% |
HELX ETF Fund Flows Chart
HELX ETF Market Cap Chart
HELX ETF NAV Growth Chart
HELX ETF Comments
no comments yet